One of the leading companies in RNA biology therapeutics has engaged The Leyden Group to identify the person who will lead their pre-clinical safety assessment program. The person who accepts this position will have full strategic and managerial oversight of the company’s toxicology program. Supervision of a group of graduate degree toxicologists is an important part of the role.

A doctoral degree in a relevant science and many years of drug development based toxicology leadership is required. Specific experience with the toxicology of RNA interference/oligonucleotide therapeutics is desired. This person will report to the company’s Senior VP of Clinical Development.

The company’s research center is located in the Great Lakes states. Relocation, or an ability to spend significant time at this location, is strongly preferred.

Search assignment #1387